Advertisements



We are Sorry, This Page doesn't Exist


Alnylam shares halted on approval of "first-of-its kind" treatment

Alnylam Pharmaceuticals Inc. shares were halted in Friday trade before news that its rare dis.....»»

Category: topSource: marketwatchAug 10th, 2018

Pain Therapeutics" stock plummets 70% after FDA advisory panel vote disappoints

Shares of Pain Therapeutics Inc. plummeted 70% toward a record low in premarket trade Wednesday, after a Food and Drug Administration advisory committee voted against the approval of Remoxy ER for the treatment of severe pain. .....»»

Category: topSource: marketwatchJun 27th, 2018

Aerie Pharmaceuticals - Positive Rhopressa Launch May Mark The Stock Price Peak

Aerie Pharmaceuticals - Positive Rhopressa Launch May Mark The Stock Price Peak.....»»

Category: topSource: seekingalphaJun 26th, 2018

Valeant Pharmaceuticals Intl Inc Shares Sink on Psoriasis Treatment Rejection by FDA

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valean.....»»

Category: topSource: investorplaceJun 19th, 2018

Idera Pharmaceuticals" stock plummets after phase 2 trial failure of dermatomyositis treatment

Idera Pharmaceuticals Inc.'s stoc.....»»

Category: topSource: marketwatchJun 12th, 2018

9 Stocks Ron Baron Continues to Buy

Aerie Pharmaceuticals tops the listCheck out Ron Baron Stock Picks » Download GuruFolio Report of Ron Baron (Updated on 05/16/2018)Related Stocks: AERI, JD, SU, HDB, GLOB, TTWO, ADMS, EA, PK,.....»»

Category: smallbizSource: nytMay 17th, 2018

Eloxx Pharmaceuticals" stock jumps toward 2 1/2-year high after orphan-drug designation granted

Shares of Eloxx Pharmaceuticals Inc. ran up 5% in midday trade Friday, putting them on track for a 2 1/2-year closing high, after the biopharmaceutical company said its ELX-02 treatment of cystinosis received orphan-drug designation fro.....»»

Category: topSource: marketwatchApr 27th, 2018

HC Wainwright Says Aerpio Pharma Flies Under The Radar Due To OTC Listing, Projects 150% Upside

Aerpio Pharmaceuticals Inc (OTC: ARPO), an OTC-listed company specializing in drug development for ocular diseases, earned a bullish review Wednesday. The interest in the stock can only go higher, as the company seeks to up-list the shares.....»»

Category: blogSource: benzingaApr 21st, 2018

Commit To Purchase Aerie Pharmaceuticals At $40, Earn 13.3% Annualized Using Options

Stock Options Channel.....»»

Category: topSource: redinewsApr 9th, 2018

Incyte"s stock set for selloff, Merck shares drop after disappointing study results of melanoma treatment

Incyte Corp. and Merck & Co. Inc. said an external data monitoring committee (eDMC) determined that results from a phas.....»»

Category: topSource: marketwatchApr 6th, 2018

Zoe"s Kitchen stock halted premarket

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 17th, 2018

Aveo Pharmaceuticals files to sell common stock, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

Vertex Pharmaceuticals shares saw a handy gain on Thursday after the FDA gave a nod to Vertex’s cystic fibrosis treatment......»»

Category: blogSource: 247wallstAug 16th, 2018

Italy"s Atlantia Plunges Most On Record After Genoa Bridge Disaster

Investors in Italy's Atlantia SpA faced record losses with the stock price crashing as much as a quarter, getting halted several times in the p.....»»

Category: blogSource: zerohedgeAug 16th, 2018

Dova Pharmaceuticals CEO Alex Sapir purchases almost $500K in stock

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2018

Stifel Bullish On GW Pharma, Sees $1.5 Billion In Epidiolex Sales By 2023

After a huge year in 2017, GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) stock has traded mostly sideways so far in 2018. But one analysts believes GW will soon return to its winning ways. Latest.....»»

Category: blogSource: benzingaAug 15th, 2018

Aerie Pharmaceuticals" Rhopressa shows significant results in IOP study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 15th, 2018

Warren Buffett"s firm adds to Apple, Teva investments

Investor Warren Buffett's company added to its stakes in Apple and Israeli drugmaker Teva Pharmaceuticals in the second quarter while tweaking several of its other stock investments......»»

Category: topSource: foxnewsAug 14th, 2018

Tesla forms committee to review Musk’s plan

Tesla's board named a special committee of three directors on Tuesday to evaluate possibly taking the electric carmaker private, although it said it had yet to see a firm offer from the company's chief executive, Elon Musk......»»

Category: videoSource: reutersAug 14th, 2018

Bsquare Reports Second Quarter 2018 Financial Results

Bsquare Reports Second Quarter 2018 Financial Results Q2 Revenue $19.2 million; Q2 EPS $(0.29); Board of Directors appoints Rob Peters and establishes a Strategic Review Committee PR Newswire BELLEVUE, Wash.,.....»»

Category: earningsSource: benzingaAug 13th, 2018